L-type calcium channels and MAP kinase contribute to thyrotropin-releasing hormone-induced depolarization in thalamic paraventricular nucleus neurons.

Abstract

In rat paraventricular thalamic nucleus (PVT) neurons, activation of thyrotropin-releasing hormone (TRH) receptors enhances neuronal excitability via concurrent decrease in a G protein-coupled inwardly rectifying K (GIRK)-like conductance and opening of a cannabinoid receptor-sensitive transient receptor potential canonical (TRPC)-like conductance. Here, we investigated the calcium (Ca²⁺) contribution to the components of this TRH-induced response. TRH-induced membrane depolarization was reduced in the presence of intracellular BAPTA, also in media containing nominally zero [Ca²⁺]_o, suggesting a critical role for both intracellular Ca²⁺ release and Ca²⁺ influx. TRH-induced inward current was unchanged by T-type Ca²⁺ channel blockade, but was decreased by blockade of high-voltage-activated Ca²⁺ channels (HVACCs). Both the pharmacologically isolated GIRK-like and the TRPC-like components of the TRH-induced response were decreased by nifedipine and increased by BayK8644, implying Ca²⁺ influx via L-type Ca²⁺ channels. Only the TRPC-like conductance was reduced by either thapsigargin or dantrolene, suggesting a role for ryanodine receptors and Ca²⁺-induced Ca²⁺ release in this component of the TRH-induced response. In pituitary and other cell lines, TRH stimulates MAPK. In PVT neurons, only the GIRK-like component of the TRH-induced current was selectively decreased in the presence of PD98059, a MAPK inhibitor. Collectively, the data imply that TRH-induced depolarization and inward current in PVT neurons involve both a dependency on extracellular Ca²⁺ influx via opening of L-type Ca²⁺ channels, a sensitivity of a TRPC-like component to intracellular Ca²⁺ release via ryanodine channels, and a modulation by MAPK of a GIRK-like conductance component.

Untitled section

Keywords: thyrotropin-releasing hormone, thalamic paraventricular neurons, L-type Ca²⁺ channels, TRPC-like and GIRK-like currents, mitogen-activated protein kinase

Article notes

Untitled section

Received 2016 Feb 25; Accepted 2016 Mar 18; Issue date 2016 Jun 1.

Author notes

thyrotropin-releasing hormone (TRH), initially isolated from hypothalamic tissue, is the hormone responsible for regulating the release of thyroid-stimulating hormone and prolactin from adenohypophyseal thyrotrophs and lactotrophs, respectively (reviewed in Ref. 26). The subsequent discovery of TRH-like immunoreactivity in neurons and axons in discrete extrahypothalamic regions of the brain together with evidence of TRH binding and mRNA for TRH receptors has triggered numerous investigations, which collectively suggest that TRH and its receptors contribute to a broad range of physiological functions that include arousal, thermogenesis, locomotion, analgesia, mood, and cognition (for reviews, see Refs. 26, 31, 50). In addition, potential therapeutic roles for TRH and TRH analogs are being sought in areas of neuroprotection, neuropsychiatric and mood disorders, narcolepsy, and certain forms of epilepsy (13, 50). Concurrent with these developments, investigations have sought to define the cellular mechanisms of TRH actions at its receptors in neurons, where TRH has long been considered to have a neurotransmitter role. Consistent with this notion, exogenous application of TRH has been shown to influence (usually enhance) neuronal excitability through a postsynaptic action in many central nervous system (CNS) regions. One area of current interest is the thalamic paraventricular nucleus (PVT), where our recent observations revealed that activation of TRH receptors was found to enhance neuronal excitability via concurrent decrease in a G protein-coupled inwardly rectifying K (GIRK)-like conductance and opening of a cannabinoid receptor-sensitive transient receptor potential canonic (TRPC)-like conductance (52, 53). The present study is an extension of this investigation, with a focus on the role of Ca²⁺ influx, Ca²⁺ release, and modulation by MAPK.

In endocrine tissues, TRH acts through a G protein-coupled receptor (GPCR) to promote an increase in phospholipase C (PLC) activity, an initial release of Ca²⁺ from intracellular stores and a later influx of Ca²⁺ through L-type voltage-gated Ca²⁺ channels (reviewed in Ref. 19). TRH also stimulates MAPK (33). However, in neurons, various investigations have not provided consistency in the role of Ca²⁺ entry vs. intracellular Ca²⁺ release in their response to TRH, or a relationship with MAPK. For example, in locus coeruleus, TRH-induced membrane depolarization was resistant to bath-applied nifedipine and TRH-induced inward current remained unaffected after intracellular application of BAPTA, a Ca²⁺ chelator (21). Also, in a majority of dissociated septal neurons, response to TRH was abolished in media containing nominally zero Ca²⁺, while other neurons remained responsive (43). In lateral hypothalamic orexin neurons, the TRH-induced inward current was reduced after substitution of strontium for Ca²⁺ in the bathing media (16). By contrast, the TRH-induced current in dissociated hippocampal CA1 neurons was similar to control in nominally zero Ca²⁺ media but was blocked after application of either thapsigargin in the external media or by intracellular BAPTA (10). Here, in PVT neurons in which the majority of neurons respond to exogenous TRH (52), we sought to address the role of Ca²⁺ influx vs. intracellular Ca²⁺ release, as well as the link to MAPK. We investigated the Ca²⁺ dependency of both the TRPC-like and GIRK-like components of the TRH-induced current. The results indicate a dependency on extracellular Ca²⁺ influx via L-type Ca²⁺ channels, a sensitivity of the TRPC-like component to Ca²⁺-induced Ca²⁺ release (CICR) via ryanodine channels, and a modulation by MAPK of the GIRK-like component.

MATERIALS AND METHODS

Experimental protocols were approved by the Ottawa Hospital Research Institute Animal Care and Use Committee. We used 3–8-wk-old Wistar rats of either sex that were housed in pairs in a temperature-controlled (22–24°C) environment with a 12:12-h light-dark (LD) cycle, with food and water available ad libitum. Our earlier studies of anterior PVT neurons revealed a diurnal variation in some of their intrinsic properties, notably resting membrane potential, low threshold-activated Ca²⁺ currents (I_T), hyperpolarization-activated cation currents (I_h), and undefined potassium conductances (25). To minimize any diurnal variations, all animals were killed by guillotine at zeitgeber time (ZT) 2–6, during their subjective quiet-day period. After quick removal, the brain was immersed in oxygenated (95% O₂-5% CO₂) and cooled (<4°C) in artificial cerebrospinal fluid (ACSF) of the following composition (in mM): 127 NaCl, 3.1 KCl, 1.3 MgCl₂, 2.4 CaCl₂, 26 NaHCO₃, and 10 glucose (osmolality 300–310 mosmol/kgH₂O; pH 7.3). Brain slices 350–400 μm in thickness were cut in the coronal plane with a Vibratome 3000 Plus Sectioning System (Vibratome, St. Louis, MO), incubated in gased ACSF for >1 h at room temperature, and then transferred to a recording chamber and superfused (2–4 ml/min) with oxygenated ACSF at 32–34°C. In all experiments, the blind-patch technique was used for whole cell current-clamp and voltage-clamp recordings using either an Axopatch 1D or Axopatch 200A, respectively (Molecular Devices, Sunnyvale, CA). Data were filtered at 2 kHz, continuously monitored and stored on disk. A Digidata 1200B interface with Clampex software (pClamp 9; Molecular Devices) was used to generate current and voltage commands, as well as to store data. Recordings were obtained from PVT neurons with borosilicate thin-walled micropipettes (resistances of 3–7 MΩ) filled with (in mM) 130 K gluconate, 10 KCl, 2 MgCl₂, 10 HEPES, 1 EGTA, 2 Mg-ATP, 0.3 Na-GTP (pH adjusted with NaOH to 7.3, osmolality ∼290 mosmol/kgH₂O). Pipettes had resistances of 4–7 MΩ. Access resistance <15 MΩ was considered acceptable. To eliminate the contribution of Na⁺-dependent conductances, we used ACSF where NaCl was replaced with Tris-Cl (52). ACSF containing 1.3 mM barium (Ba²⁺) was utilized to eliminate the contribution of GIRK channels to TRH-induced inward currents (52). Series resistance was compensated for >65% and was regularly checked throughout the experiment by monitoring current responses to brief 5-mV hyperpolarizing steps. Basic intrinsic properties of PVT neurons in this study were consistent with those previously reported for this ZT recording time (25). Membrane voltages were corrected for liquid junction potential (normal ACSF, −13 mV; low Na⁺ ACSF, −23 mV). Voltage-clamp analyses used a standard ramp protocol (step from −63 mV to −43 mV for 0.5 s and then ramped from −43 mV to −113 mV or −123 mV in 3 s followed by step back to −63 mV) from a holding potential of −63 mV. The net TRH-induced current was obtained by subtracting the control ramp response from that obtained during the TRH-induced response. Off-line analyses were performed using Clampfit version 9 or 10 (pClamp 9 or 10; Molecular Devices). As recently reported, TRH-induced inward currents in PVT neurons rapidly desensitize (52). Therefore, the data from this study reflect responses to a single TRH application per neuron per slice. Results are expressed as means ± SE. Statistical comparisons between control and experimental values (P < 0.05 and better) were determined using both the paired or unpaired Student's t-test and ANOVA (SigmaPlot 10 and SigmaStat 3, Systat Software).

BayK8644, ω-Agatoxin IVA, thapsigargin, dantrolene, and W7 were purchased from Tocris Bioscience (R&D Systems, Minneapolis, MN). Nifedipine, BAPTA, ω-conotoxin GVIA, and PD98059 were purchased from Sigma Chemical (St. Louis, MO). Tetrodotoxin (TTX) was purchased from Alomone Labs (Jerusalem, Israel). Z941 was kindly provided by Dr. Terry Snutch from University of British Columbia, Canada. Most drugs were bath applied at the concentrations indicated.

RESULTS

We first evaluated the TRH response under current-clamp conditions. During intracellular dialysis with 10 mM BAPTA in the pipette media, the membrane depolarization induced by a brief bath application of TRH (100 nM for 60 s) was significantly reduced when compared with controls (Fig. 1, A, B, D; n = 5; one-way ANOVA, F = 17.024, P < 0.001). There was no difference in resting membrane potential between these two groups (one-way ANOVA, F = 2.254, P = 0.143). To evaluate a dependency on Ca²⁺ influx, we next used ACSF with nominally zero Ca²⁺. Here, the TRH-induced depolarization was also significantly reduced (Fig. 1, C and D; n = 6; one-way ANOVA, F = 23.705, P < 0.001). The data suggest major roles both for Ca²⁺ influx and intracellular Ca²⁺ in the TRH-induced response.

External Ca2+ plays a major role in thyrotropin-releasing hormone (TRH) receptor signaling. A: whole cell current-clamp recording illustrates the typical response of paraventricular thalamic nucleus (PVT) neurons to a 60-s bath application of 100 nM TRH (bar). B and C: whole cell current-clamp recordings from two other PVT neurons show smaller TRH responses when TRH was applied either during the internal perfusion with 10 mM BAPTA (B) or in artificial cerebrospinal fluid (ACSF) with nominally 0 mM Ca2+ (for 15 min; C). D: summary histogram illustrates TRH-induced membrane depolarization in the presence of 100 nM TRH alone (black bar; for 60 s) or when TRH was applied either during internal perfusion with 10 mM BAPTA or in ACSF with nominally 0 mM Ca2+ (gray bars). Data are expressed as means ± SE. ***P < 0.001. — Fig. 1.External Ca²⁺ plays a major role in thyrotropin-releasing hormone (TRH) receptor signaling. A: whole cell current-clamp recording illustrates the typical response of paraventricular thalamic nucleus (PVT) neurons to a 60-s bath application of 100 nM TRH (bar). B and C: whole cell current-clamp recordings from two other PVT neurons show smaller TRH responses when TRH was applied either during the internal perfusion with 10 mM BAPTA (B) or in artificial cerebrospinal fluid (ACSF) with nominally 0 mM Ca²⁺ (for 15 min; C). D: summary histogram illustrates TRH-induced membrane depolarization in the presence of 100 nM TRH alone (black bar; for 60 s) or when TRH was applied either during internal perfusion with 10 mM BAPTA or in ACSF with nominally 0 mM Ca²⁺ (gray bars). Data are expressed as means ± SE. ***P < 0.001.

TRH-induced inward current depends on Ca²⁺ entry through L-type Ca²⁺ channels.

Recordings in voltage-clamp mode in the presence of 1 μM TTX confirmed a dependency of the TRH-induced inward current on external Ca²⁺. In ACSF containing nominally zero Ca²⁺, the response to TRH (100 nM applied for 60 s) was significantly reduced (Fig. 2, A and E; one-way ANOVA, F = 10.984, P = 0.003). Because TRH responses occurred from a holding potential around −63 mV, a voltage range at which low-voltage activated T-type Ca²⁺ channels are fully functional (see Fig. 3A in Ref. 25), we next evaluated the TRH-induced current in the presence of a Z941 (1 μM), a specific blocker of T-type Ca²⁺ channels (44). Whereas this treatment markedly reduced the T-type Ca²⁺ current (24), the TRH-induced current was not changed (Fig. 2, B and E; one-way ANOVA on ranks, H = 0.962, P = 0.327). However, the TRH-induced current was significantly reduced during bath application of cadmium (Cd²⁺; 100 μM), a nonselective blocker of high-voltage activated Ca²⁺ channels (HVACCs) (Fig. 2E; one-way ANOVA on ranks, H = 10.524, P = 0.001). While Cd²⁺ at this concentration was reported to impair T-type Ca²⁺ function in cultured thalamic neurons (34), our observations in slice preparations revealed no significant attenuation of the T-type Ca²⁺ channels in PVT neurons (see Fig. 2C in Ref. 55). On the basis of their pharmacological profiles, HVACCs have been further divided into N-, P/Q-, L-, and R-types (5). Because bath application of the combination of ω-Agatoxin IVA (200 nM) with ω-conotoxin GVIA (400 nM) did not affect the TRH-induced current (Fig. 2E; one-way ANOVA, F = 0.013, P = 0.981), a potential contribution from N-, P-, and Q-type channels would seem unlikely.

Activation of L-type Ca2+ channels is essential for the coupling of TRH receptor to both G protein-coupled inwardly rectifying K (GIRK)- and transient receptor potential canonical (TRPC)-like channels. Sample voltage-clamp traces done in the presence of 1 μM tetrodotoxin (TTX). A: typical trace showing reduced response to bath-applied TRH (100 nM for 60 s) in ACSF with nominally 0 mM Ca2+ (for 15 min). B: trace from another PVT neuron illustrates normal response to TRH in the presence of T-type Ca2+ channel blocker Z941 (1 μM for 10 min). C: trace from another PVT neuron to illustrate a reduced TRH-induced inward current in the presence of L-type Ca2+ channel blocker nifedipine (3 μM for 10 min). D: trace exhibiting both enhanced amplitude and duration of TRH-induced inward current during coadministration of L-type Ca2+ channel agonist BayK8644 (10 μM). E: summary histogram (number reflects cells tested in each condition) illustrates TRH-induced inward current either alone (100 nM; black bars) and when applied in ACSF with nominally 0 mM Ca2+, Z941 (1 μM), cadmium (100 μM for 10 min), ω-conotoxin GVIA (400 nM) and ω-Agatoxin IVA (con/aga; 200 nM), nifedipine (3 μM), and BayK8644 (10 μM). Note that TRH (black bars) or TRH in the presence of either nifedipine (dark gray bars) or BayK8644 (dark gray patterned bars) was applied in three different external media: control ACSF (expressing GIRK+TRPC currents), ACSF where NaCl was replaced with Tris-Cl to isolate GIRK-like channels (low Na+-GIRK), and ACSF with 1.3 mM Ba2+ to isolate TRPC-like channels (1.3 mM Ba2+-TRPC). Data are expressed as means ± SE. *P < 0.05; **P < 0.01; ***P < 0.001. — Fig. 2.Activation of L-type Ca²⁺ channels is essential for the coupling of TRH receptor to both G protein-coupled inwardly rectifying K (GIRK)- and transient receptor potential canonical (TRPC)-like channels. Sample voltage-clamp traces done in the presence of 1 μM tetrodotoxin (TTX). A: typical trace showing reduced response to bath-applied TRH (100 nM for 60 s) in ACSF with nominally 0 mM Ca²⁺ (for 15 min). B: trace from another PVT neuron illustrates normal response to TRH in the presence of T-type Ca²⁺ channel blocker Z941 (1 μM for 10 min). C: trace from another PVT neuron to illustrate a reduced TRH-induced inward current in the presence of L-type Ca²⁺ channel blocker nifedipine (3 μM for 10 min). D: trace exhibiting both enhanced amplitude and duration of TRH-induced inward current during coadministration of L-type Ca²⁺ channel agonist BayK8644 (10 μM). E: summary histogram (number reflects cells tested in each condition) illustrates TRH-induced inward current either alone (100 nM; black bars) and when applied in ACSF with nominally 0 mM Ca²⁺, Z941 (1 μM), cadmium (100 μM for 10 min), ω-conotoxin GVIA (400 nM) and ω-Agatoxin IVA (con/aga; 200 nM), nifedipine (3 μM), and BayK8644 (10 μM). Note that TRH (black bars) or TRH in the presence of either nifedipine (dark gray bars) or BayK8644 (dark gray patterned bars) was applied in three different external media: control ACSF (expressing GIRK+TRPC currents), ACSF where NaCl was replaced with Tris-Cl to isolate GIRK-like channels (low Na⁺-GIRK), and ACSF with 1.3 mM Ba²⁺ to isolate TRPC-like channels (1.3 mM Ba²⁺-TRPC). Data are expressed as means ± SE. *P < 0.05; **P < 0.01; ***P < 0.001.

TRH-induced activation of TRPC-like channels involves Ca2+-induced Ca2+ release. A: the mean I–V relationship of the net TRH-generated current in the presence of either thapsigargin (2 μM for 15 min; n = 7; black circles) or dantrolene (20 μM for 15 min; n = 12; dark gray circles) obtained by subtracting control membrane current responses from those in TRH. Data are presented as mean (circles) ± SE (light gray lines). Note that the I-V reversals approximate the K+ equilibrium potential under these experimental conditions. B: summary histogram of normalized amplitude of TRH-induced currents in the presence of either thapsigargin (black bars) or dantrolene (dark gray bars) in three different external media: control ACSF (expressing GIRK+TRPC currents), ACSF where NaCl was replaced with Tris-Cl to isolate GIRK-like channels (low Na+-GIRK), and ACSF with 1.3 mM Ba2+ to isolate TRPC-like channels (1.3 mM Ba2+-TRPC). Note that there was no current reduction when GIRK-like channels were isolated. Data are expressed as means ± SE. *P < 0.05; **P < 0.01; ***P < 0.001; number reflects cells tested in each condition. — Fig. 3.TRH-induced activation of TRPC-like channels involves Ca²⁺-induced Ca²⁺ release. A: the mean *I–V* relationship of the net TRH-generated current in the presence of either thapsigargin (2 μM for 15 min; n = 7; black circles) or dantrolene (20 μM for 15 min; n = 12; dark gray circles) obtained by subtracting control membrane current responses from those in TRH. Data are presented as mean (circles) ± SE (light gray lines). Note that the *I-V* reversals approximate the K⁺ equilibrium potential under these experimental conditions. B: summary histogram of normalized amplitude of TRH-induced currents in the presence of either thapsigargin (black bars) or dantrolene (dark gray bars) in three different external media: control ACSF (expressing GIRK+TRPC currents), ACSF where NaCl was replaced with Tris-Cl to isolate GIRK-like channels (low Na⁺-GIRK), and ACSF with 1.3 mM Ba²⁺ to isolate TRPC-like channels (1.3 mM Ba²⁺-TRPC). Note that there was no current reduction when GIRK-like channels were isolated. Data are expressed as means ± SE. *P < 0.05; **P < 0.01; ***P < 0.001; number reflects cells tested in each condition.

However, since dihydropyridine-sensitive L-type Ca²⁺ channels can be activated at low hyperpolarized voltages (28), we next assessed the response to TRH in the presence of bath-applied nifedipine (3 μM), a specific L-type Ca²⁺ channel blocker. Here, the TRH-induced inward current was reduced (Fig. 2, C and E; one-way ANOVA, F = 16.252, P < 0.001). Conversely, in the presence of BayK8644 (10 μM), an activator of L-type Ca²⁺ channels (5), the TRH-induced current was both enhanced (Fig. 2, D and E; one-way ANOVA, F = 6.691, P = 0.015) and prolonged in duration (Fig. 2D). These observations suggest that L-type Ca²⁺ channels contribute significantly to TRH receptor signaling in PVT neurons.

We next assessed the modulation of L-type Ca²⁺ channels with an antagonist (nifedipine) and an activator (BayK8644) under recording conditions that blocked either the contribution of TRPC-like channels (low Na⁺) or GIRK-like channels (1.3 mM Ba²⁺) to the TRH-induced response (52). As illustrated in Fig. 2E, both components of the TRH-induced current were reduced in the presence of nifedipine and enhanced in media containing BayK8644, suggesting that L-type Ca²⁺ channels contribute both to the closing of the GIRK-like channel component and to the opening of the TRPC-like channel component of the TRH-induced current in these neurons.

TRH-induced opening of TRPC-like channels relies on functional coupling between ryanodine receptors and L-type Ca²⁺ channels.

The observation that chelation of intracellular Ca²⁺ ions with BAPTA decreased TRH-induced responses suggests that Ca²⁺-dependent signaling pathways play a critical role. As we previously reported, PVT neurons display evidence of CICR (36). Therefore, we next evaluated the effect of bath-applied thapsigargin (2 μM), a noncompetitive inhibitor of sarco/endoplasmatic reticulum Ca²⁺ ATPase (SERCA). Under these experimental conditions, not only was the TRH-induced current significantly decreased (Fig. 3B; one-way ANOVA, F = 7.062, P = 0.013), but the net TRH current now reversed at −105 mV, close to the K⁺ equilibrium potential (Fig. 3A). This suggests that thapsigargin suppresses the contribution of the TRH-induced response derived from opening of TRPC-like channels. Indeed, in the presence of low Na⁺ ACSF, where the contribution from TRPC-like channels is eliminated (52), the response of PVT neurons in the presence or absence of thapsigargin was identical with control data (Fig. 3B; one-way ANOVA, F = 0.699, P = 0.451). However, when tested in ACSF containing 1.3 mM Ba²⁺ (to eliminate the contribution of K⁺ conductances; Ref. 52), the amplitude of the TRH-induced inward current was significantly reduced by thapsigargin (Fig. 3B; one-way ANOVA, F = 10.476, P = 0.005), suggesting an involvement of CICR in TRH-induced opening of TRPC-like channels.

CICR can be mediated through activation of either inositol 1, 4, 5-trisphosphate receptors (IP₃Rs) or ryanodine receptors (RyRs). Data from our previous investigation indicated that IP₃Rs are unlikely to be involved in the TRH-induced inward current (52, 53). However, L-type Ca²⁺ channels may be functionally coupled with RyRs (6). To address a potential L-type channel coupling with RyRs, we next bath-applied dantrolene (20 μM), a specific RyR inhibitor and obtained results that were similar to thapsigargin, i.e., the net TRH current reversed close to the K⁺ equilibrium potential (Fig. 3A) and the TRH-induced inward current was significantly reduced (Fig. 3B; one-way ANOVA, F = 10.389, P = 0.003). In addition, the TRH response was unchanged in low Na⁺ ACSF (Fig. 3B; one-way ANOVA, F = 0.864, P = 0.370) but significantly smaller in ACSF containing 1.3 mM Ba²⁺ (Fig. 3B: one-way ANOVA, F = 20.356, P < 0.001). These data suggest that CICR through functional coupling between L-type Ca²⁺ channels and RyRs contributes to the TRH-induced activation of TRPC-like channels.

MAPK participates in TRH-induced suppression of GIRK-like channels.

Investigations in various endocrine-like cell lines reveal that activation of TRH receptors can lead to stimulation of MAPK (33, 41). To assess a possible participation of MAPK in the TRH-induced response in PVT neurons, we evaluated the impact of PD98059, a specific inhibitor of MAPK (1) on the TRH-induced current. In the presence of PD98059 (50 μM), the net TRH-induced inward current displayed no reversal potential, and the amplitude was reduced when compared with control (Fig. 4, A and B; one-way ANOVA, F = 8.817, P = 0.006), suggesting that activation of MAPK could be involved in the regulation of TRH-induced decrease of a GIRK-like conductance. In support of this, we noted that the TRH-induced current was significantly reduced when PD98059 was applied under conditions in which the activity of TRPC-like channels was inhibited (low Na⁺ data in Fig. 4B; one-way ANOVA, F = 34.764, P < 0.001). By contrast, when tested in ACSF containing 1.3 mM Ba²⁺, PD98059 did not alter the TRH-induced increase in TRPC-like channel conductance (Ba²⁺ data in Fig. 4B; one-way ANOVA, F = 0.002, P = 0.962), suggesting that MAPK only participates in the regulation of GIRK channels.

TRH-induced activation of GIRK-like channels involves MAPK. A: the mean I-V relationship of the net TRH-generated current in the presence of PD98059 (50 μM for 15 min; n = 5; black circles) obtained by subtracting control membrane current responses from those in TRH. Data are presented as means (black circles) ± SE (gray lines). Note that the I-V relationship does not display a reversal under these experimental conditions. B: summary histogram of normalized amplitude of TRH-induced currents in the presence of PD98059 in three different external media: control ACSF (expressing GIRK+TRPC currents; black bar), ACSF where NaCl was replaced with Tris-Cl to isolate GIRK-like channels (low Na+- GIRK), and ACSF with 1.3 mM Ba2+ to isolate TRPC-like channels (1.3 mM Ba2+-TRPC). Note that there was no current reduction when TRPC-like channels were isolated. Data are expressed as means ± SE. **P < 0.01; ***P < 0.001; number reflects cells tested in each condition. — Fig. 4.TRH-induced activation of GIRK-like channels involves MAPK. A: the mean *I-V* relationship of the net TRH-generated current in the presence of PD98059 (50 μM for 15 min; n = 5; black circles) obtained by subtracting control membrane current responses from those in TRH. Data are presented as means (black circles) ± SE (gray lines). Note that the *I-V* relationship does not display a reversal under these experimental conditions. B: summary histogram of normalized amplitude of TRH-induced currents in the presence of PD98059 in three different external media: control ACSF (expressing GIRK+TRPC currents; black bar), ACSF where NaCl was replaced with Tris-Cl to isolate GIRK-like channels (low Na⁺- GIRK), and ACSF with 1.3 mM Ba²⁺ to isolate TRPC-like channels (1.3 mM Ba²⁺-TRPC). Note that there was no current reduction when TRPC-like channels were isolated. Data are expressed as means ± SE. **P < 0.01; ***P < 0.001; number reflects cells tested in each condition.

DISCUSSION

Investigations of the TRH-induced responses in adenohypophyseal cell lines and in various expression systems have indicated that TRH-induced secretion is generally triggered by an elevation of intracellular calcium ([Ca²⁺]_i), with a first phase of the response involving Ca²⁺ release from intracellular stores, followed by a delayed prolonged elevation of [Ca²⁺]_i through influx via voltage-gated Ca²⁺ channels (e.g., Ref. 19). However, in neurons, although Ca²⁺ is an important contributor to the TRH-induced responses, there is considerable diversity in terms of the role and importance of Ca²⁺ entry vs. intracellular Ca²⁺ release in different CNS regions. For example, within the diencephalon, one study using fura-2-loaded dissociated septal neurons revealed their response to TRH was either release of Ca²⁺ from internal stores, Ca²⁺ entry, or both (43). In thalamus, substitution of strontium for Ca²⁺ in the external media was noted to attenuate a TRH-induced slow afterdepolarization in lateral geniculate and perigeniculate neurons (4) and to reduce TRH-induced inward current in lateral hypothalamic orexin/hypocretin neurons (16), suggesting a role for Ca²⁺ influx. In rat PVT neurons, where there is a high density of TRH receptors (18), we recently reported that the majority of cells respond to low concentrations of exogenous TRH with an inward current that is mediated by concurrent decrease in a GIRK-like conductance and increase in a TRPC-like channel conductance, the latter linked to intracellular cannabinoid receptors (52, 53). While we have no answer as to the variability in the data on the roles of Ca²⁺ in the responses to TRH in different CNS sites, the present analysis does advance our understanding of the roles of calcium in TRH receptor signaling in PVT neurons. Collectively, the data suggest that a TRH-induced opening of L-type HVACCs is fundamental to both the TRH-induced closing of GIRK-like channels and the opening of TRPC-like channels, that the opening of TRPC-like channels is dependent on CICR, and that a MAPK participates in the closing of GIRK-like channels. Figure 5 is intended to present an overview of known TRH receptor signaling pathways in PVT neurons.

Fig. 5.The illustration depicts an overview of the major TRH receptor signaling pathways in PVT neurons. The data are based on the current study and our recent reports on TRH receptors (52, 53).

In endocrine cell lines, a role for external Ca²⁺ and for L-type Ca²⁺ channels has been well documented in the TRH receptor signaling pathway leading to hormone secretion, and an involvement of L-type HVACCs is part of TRH receptor signaling (39, 45). However, Ca²⁺ influx appears to follow CICR in endocrine cell models (reviewed in Refs. 12 and 19). By contrast, the data from the TRH-induced responses in PVT neurons suggest that influx via L-type Ca²⁺ channels is a critical early step in TRH receptor signaling, a judgment based on the following observations. First, TRH-induced depolarization is decreased in the presence of ACSF containing nominally zero Ca²⁺, attesting to the importance of extracellular Ca²⁺. Second, although TRH-induced inward current is not affected after blockade of T-type Ca²⁺ channels with Z941, sensitivity to Cd²⁺ supports an involvement of high-voltage activated Ca²⁺ channels (HVACCs). While Cd²⁺ at the concentration used here has been reported to impair T-type channel current in cultured thalamic neurons (34), we have observed no significant influence on T-type Ca²⁺ channel current in PVT neurons in our slice preparations (see Fig. 2C in Ref. 55). Since the TRH-induced inward current is insensitive to coapplication of ω-Agatoxin IVA/ω-conotoxin GVIA, yet modulated with nifedipine and BayK8644, the pharmacological profile seems consistent with an engagement of L-type HVACCs (5). It has been shown that nifedipine may interfere with T-type Ca²⁺ channel function (37). However, its main target appears to be the Ca_v3.2 subtype, which has the lowest expression in PVT neurons (see Fig. 3B in Ref. 25). The TRH-induced response component that is mediated by the closing of GIRK-like channels is not blocked by agents acting on PC-PLC and cannabinoid receptors (53) or on CICR (Fig. 3, current study) but is almost equally as reduced as the TRPC-mediated response component in the presence of nifedipine or BayK8644 (Fig. 2E). Therefore, these data suggest that activation of the L-type HVACC is a foremost step in the TRH receptor signaling pathways for both closure of the GIRK-like channels and opening of the TRPC-like channels. To the best of our knowledge, an involvement of L-type HVACCs in neuronal responses to TRH has not been verified previously. Of interest, and for similarity, direct activation of L-type HVACCs by G protein-coupled receptors in CNS neurons has been reported for cholinergic receptors (54, 56), orexin receptors (23, 48), and glutamate metabotropic receptors (56, 58).

L-type Ca²⁺ channels are formed by the Ca_v1 family, which consists of four isoforms of the α₁ pore-forming subunit (Ca_v1.1 to Ca_v1.4; reviewed in Refs. 51 and 59). While L-type HVACCs are commonly activated at suprathreshold membrane potentials, a functional contribution to resting membrane potential has also been reported (29). Although there is the possibility that poor spatial clamping of dendrites may allow the voltage to be more positive and, thus, contribute to Ca²⁺ influx at remote sites, we noted minimal inward current under basal conditions at −63 mV. Recently, it has been reported that the Ca_v1.3 gene product, in particular, can be activated at relatively hyperpolarized membrane potentials that may overlap with low-threshold T-type channels (49). Indeed, L-type Ca_v1.3 isoforms are present in PVT (17, 42). However, our data indicate that blockade of T-type channels had no influence on the TRH-induced inward current.

Chelation of intracellular Ca²⁺ ions with BAPTA decreased the TRH-induced response, suggesting that Ca²⁺-dependent intracellular processes have a role. Consistent with this hypothesis, the data show that both thapsigargin and dantrolene decrease the TRPC-mediated component of the TRH-induced response, implying that CICR through ryanodine receptors is part of the signaling pathway leading to opening of TRPC-like channels in PVT neurons. A functional coupling between ryanodine receptors and L-type HVACCs has been established in neurons (6). Interestingly, it has also recently been suggested that there is a cross-signaling between L-type HVACCs and RyRs that control Ca²⁺ influx during neuronal activity in lateral geniculate thalamocortical relay neurons (35).

We recently reported observations suggesting that activation of TRH receptors can lead to synthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG; 53). 2-AG is perhaps the most abundant endocannabinoid in the rat brain (2). Since 2-AG synthesis can depend of an increase in postsynaptic intracellular Ca²⁺ concentration (32, 38, 40), data from the current study would be in agreement with an involvement of intracellular Ca²⁺ as part of one or more pathways that lead to activation of cannabinoid receptors and consequent opening of TRPC-like channels. TRH-induced currents have a profile suggestive of TRPC4/5-like channels (52). In addition, it has been proposed that enhanced Ca²⁺ entry through either CICR or voltage-dependent Ca²⁺ channels is sufficient for TRPC5 channel activation (14). Therefore, we might speculate that Ca²⁺ ions have a dual function, one as a possible cofactor for 2-AG synthesis, another as a TRPC-like channel gating molecule.

Activation of many GPCRs leads to an increase in MAPK activity. In pituitary cells expressing endogenous TRH receptors and in a number of cell lines expressing transfected TRH receptors, exposure to TRH has been shown to stimulate MAPK (22, 33, 46). MAPK cascades can couple GPCRs to the nucleus (15), and MAPK is required for TRH stimulation of transcription of certain genes (46). Comparatively little is known with respect to a role of MAPK in TRH receptor signaling in neurons. In a study focusing on a TRH-induced increase in spontaneous inhibitory postsynaptic currents, exposure to the MAPK kinase inhibitor PD98059 reduced ongoing events to ∼60% of control but did not block TRH-induced events, suggesting that the MAPK pathway was not involved (9). Conversely, our observations in PVT neurons do suggest an involvement of MAPK in the TRH-induced current, specifically in the closure of GIRK-like channels. This was perhaps surprising given the fact that TRH responses mediated by the opening of TRPC-like channels involves activation of endogenous cannabinoid receptors (53), and MAPK is known to be part of their signaling pathways (3). On the other hand, a coupling between GIRK channels and MAPK has been suggested before (7, 27). Although we have not pursued the role of MAPK further here, it interesting to note that participation of both L-type HVACCs and MAPK are essential in prokineticin 2 receptor-mediated depolarization of neurons in the subfornical organ (11) and for estrogen receptor-induced protection of hippocampal neurons (57).

Perspectives and Significance

Almost five decades since its initial characterization as a hormone and a neuropeptide, the physiological role of TRH in brain has remained somewhat elusive. The fact that TRH-immunoreactive axons detected in the midline thalamus likely originate from TRH-synthesizing neurons whose somata are distributed in the hypothalamus and the brain stem (20, 30, 47) suggests that endogenously released TRH may contribute in the integration of the metabolic and energy-sensing functions of the hypothalamus with the motivated behavior functions proposed for neurons in the midline thalamus. We propose that the data presented here expose a novel signaling pathway engaged by these specific TRH receptors. Whereas any systemic pharmacological manipulation that targets L-type HVACCs is likely to alter the TRH sensitivity in midline thalamic neurons, the introduction of optogenetic technology now offers the potential to selectively activate endogenous release of TRH in this thalamic location and to monitor behavioral and physiological consequences. For example, since TRH has the capability to modulate neuronal firing patterns (e.g., from burst to tonic firing), this may be a clue toward understanding some of the behavioral functions (e.g., arousal and enhanced vigilance, mood, and motivation) attributed to both TRH and to neurons in the midline thalamus (8).

GRANTS

This research was supported by the Canadian Institutes of Health Research (CIHR) 77745. L. P. Renaud held the GlaxoSmithKline/CIHR/J. David Grimes Chair at the University of Ottawa.

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the authors.

AUTHOR CONTRIBUTIONS

M.K., L.Z., and L.P.R. conception and design of research; M.K. and L.Z. analyzed data; M.K., L.Z., and L.P.R. interpreted results of experiments; M.K. and L.Z. prepared figures; M.K. and L.P.R. drafted manuscript; M.K. and L.P.R. edited and revised manuscript; M.K., L.Z., and L.P.R. approved final version of manuscript; L.Z. performed experiments.

ACKNOWLEDGMENTS

We thank Elaine Coderre for technical assistance.

REFERENCES

Untitled section

References

1.Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270: 27,489–27,494, 1995.
2.Bisogno T, Ortar G, Petrosino S, Morera E, Palazzo E, Nalli M, Maione S, Di Marzo V. Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. Biochim Biophys Acta 1791: 53–60, 2009.
3.Bosier B, Muccioli GG, Hermans E, Lambert DM. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem Pharmacol 80: 1–12, 2010.
4.Broberger C, McCormick DA. Excitatory effects of thyrotropin-releasing hormone in the thalamus. J Neurosci 25: 1664–1673, 2005.
5.Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57: 411–425, 2005.
6.Chavis P, Fagni L, Lansman JB, Bockaert J. Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature 382: 719–722, 1996.
7.Clayton CC, Xu M, Chavkin C. Tyrosine phosphorylation of Kir3 following κ-opioid receptor activation of p38 MAPK causes heterologous desensitization. J Biol Chem 284: 31,872–31,881, 2009.
8.Colavito V, Tesoriero C, Wirtu AT, Grassi-Zucconi G, Bentivoglio M. Limbic thalamus and state-dependent behavior: The paraventricular nucleus of the thalamic midline as a node in circadian timing and sleep/wake-regulatory networks. Neurosci Biobehav Rev 54: 3–17, 2015.
9.Deng PY, Porter JE, Shin HS, Lei S. Thyrotropin-releasing hormone increases GABA release in rat hippocampus. J Physiol 577: 497–511, 2006.
10.Ebihara S, Akaike N. Potassium currents operated by thyrotrophin-releasing hormone in dissociated CA1 pyramidal neurones of rat hippocampus. J Physiol 472: 689–710, 1993.
11.Fry M, Cottrell GT, Ferguson AV. Prokineticin 2 influences subfornical organ neurons through regulation of MAP kinase and the modulation of sodium channels. Am J Physiol Regul Integr Comp Physiol 295: R848–R856, 2008.
12.Galas L, Lamacz M, Garnier M, Roubos EW, Tonon MC, Vaudry H. Involvement of extracellular and intracellular calcium sources in TRH-induced α-MSH secretion from frog melanotrope cells. Mol Cell Endocrinol 138: 25–39, 1998.
13.Gary KA, Sevarino KA, Yarbrough GG, Prange AJ Jr, Winokur A. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther 308: 410–416, 2003.
14.Gross SA, Guzmán GA, Wissenbach U, Philipp SE, Zhu MX, Bruns D, Cavalié A. TRPC5 is a Ca²⁺-activated channel functionally coupled to Ca²⁺-selective ion channels. J Biol Chem 284: 34,423–34,432, 2009.
15.Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273: 1839–1842, 1998.
16.Hara J, Gerashchenko D, Wisor JP, Sakurai T, Xie X, Kilduff TS. Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons. J Neurosci 29: 3705–3714, 2009.
17.Hetzenauer A, Sinnegger-Brauns MJ, Striessnig J, Singewald N. Brain activation pattern induced by stimulation of L-type Ca²⁺-channels: contribution of Ca_v1.3 and Ca_v12 isoforms. Neuroscience 139: 1005–1015, 2006.
18.Heuer H, Schäfer MKH, O'Donnell D, Walker P, Bauer K. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol 428: 319–336, 2000.
19.Hinkle PM, Nelson EJ, Ashworth R. Characterization of the calcium response to thyrotropin-releasing hormone in lactotrophs and GH cells. Trends Endocrinol Metab 7: 370–374, 1996.
20.Horjales-Araujo E, Hellysaz A, Broberger C. Lateral hypothalamic thyrotropin-releasing hormone neurons: distribution and relationship to histochemically defined cell populations in the rat. Neuroscience 277: 87–102, 2014.
21.Ishibashi H, Nakahata Y, Eto K, Nabekura J. Excitation of locus coeruleus noradrenergic neurons by thyrotropin-releasing hormone. J Physiol 587: 5709–5721, 2009.
22.Kanasaki H, Fukunaga K, Takahashi K, Miyazaki K, Miyamoto E. Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells. Biol Reprod 61: 319–325, 1999.
23.Kohlmeier KA, Inoue T, Leonard CS. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. J Neurophysiol 92: 221–235, 2004.
24.Kolaj M, Zhang L, Renaud LP. Novel coupling between TRPC-like and K_Na channels modulate low threshold spike-induced afterpotentials in rat thalamic midline neurons. Neuropharmacology 86: 88–96, 2014.
25.Kolaj M, Zhang L, Rønnekleiv OK, Renaud LP. Midline thalamic paraventricular nucleus neurons display diurnal variation in resting membrane potentials, conductances, and firing patterns in vitro. J Neurophysiol 107: 1835–1844, 2012.
26.Lechan RM, Fekete C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 153: 209–235, 2006.
27.Lemos JC, Roth CA, Messinger DI, Gill HK, Phillips PE, Chavkin C. Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism. J Neurosci 32: 12325–36, 2012.
28.Lipscombe D, Helton TD, Xu W. L-type calcium channels: the low down. J Neurophysiol 92: 2633–2641, 2004.
29.Magee JC, Avery RB, Christie BR, Johnston D. Dihydropyridine-sensitive, voltage-gated Ca²⁺ channels contribute to the resting intracellular Ca²⁺ concentration of hippocampal CA1 pyramidal neurons. J Neurophysiol 76: 3460–3470, 1996.
30.Merchenthaler I, Csernus V, Csontos C, Petrusz P, Mess B. New data on the immunocytochemical localization of thyrotropin-releasing hormone in the rat central nervous system. Am J Anat 181: 359–376, 1988.
31.Nillni EA, Sevarino KA. The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr J 20: 599–648, 1999.
32.Oka S, Arai S, Waku K, Tokumura A, Sugiura T. Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes. J Biochem 141: 687–697, 2007.
33.Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, Miyake A, Saltiel AR. Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. J Biol Chem 269: 3783–3788, 1994.
34.Pfrieger FW, Veselovsky NS, Gottmann K, Lux HD. Pharmacological characterization of calcium currents and synaptic transmission between thalamic neurons in vitro. J Neurosci 12: 4347–4357, 1992.
35.Rankovic V, Ehling P, Coulon P, Landgraf P, Kreutz MR, Munsch T, Budde T. Intracellular Ca²⁺ release-dependent inactivation of Ca²⁺ currents in thalamocortical relay neurons. Eur J Neurosci 31: 439–449, 2010.
36.Richter TA, Kolaj M, Renaud LP. Low voltage-activated Ca²⁺ channels are coupled to Ca²⁺-induced Ca²⁺ release in rat thalamic midline neurons. J Neurosci 25: 8267–8271, 2005.
37.Shcheglovitov A, Zhelay T, Vitko Y, Osipenko V, Perez-Reyes E, Kostyuk P, Shuba Y. Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca²⁺ channels. Biochem Pharmacol 69: 841–854, 2005.
38.Shonesy BC, Winder DG, Patel S, Colbran RJ. The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium. Neuropharmacology 91: 57–62, 2015.
39.Shupnik MA, Weck J, Hinkle PM. Thyrotropin (TSH)-releasing hormone stimulates TSH-β promoter activity by two distinct mechanisms involving calcium influx through L type Ca²⁺ channels and protein kinase C. Mol Endocrinol 10: 90–99, 1996.
40.Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773–778, 1997.
41.Sun Y, Lu X, Gershengorn M. Thyrotropin-releasing hormone receptors—similarities and differences. J Mol Endocrinol 30: 87–97, 2003.
42.Tan BZ, Jiang F, Tan MY, Yu D, Huang H, Shen Y, Soong TW. Functional characterization of alternative splicing in the C terminus of L-type Ca_v1.3 channels. J Biol Chem 286: 42,725–42,735, 2011.
43.Toledo-Aral J, Castellano A, Ureña J, López-Barneo J. Dual modulation of K⁺ currents and cytosolic Ca²⁺ by the peptide TRH and its derivatives in guinea-pig septal neurones. J Physiol 472: 327–340, 1993.
44.Tringham E, Powell KL, Cain SM, Kuplast K, Mezeyova J, Weerapura M, Eduljee C, Jiang X, Smith P, Morrison JL, Jones NC, Braine E, Rind G, Fee-Maki M, Parker D, Pajouhesh H, Parmar M, O'Brien TJ, Snutch TP. T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures. Sci Transl Med 4: 121ra19, 2012.
45.Vargas MA, Cisneros M, Joseph-Bravo P, Charli JL. Thyrotropin-releasing hormone-induced down-regulation of pyroglutamyl aminopeptidase II activity involves L-type calcium channels and cam kinase activities in cultures of adenohypophyseal cells. J Neuroendocrinol 14: 184–193, 2002.
46.Wang YH, Maurer RA. A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter. Mol Endocrinol 13: 1094–1104, 1999.
47.Wittmann G, Füzesi T, Singru PS, Liposits Z, Lechan RM. Efferent projections of thyrotropin-releasing hormone-synthesizing neurons residing in the anterior subdivision of the hypothalamic paraventricular nucleus. J Comp Neurol 515: 313–330, 2009.
48.Xia JX, Fan SY, Yan J, Chen F, Li Y, Yu ZP, Hu ZA. Orexin A-induced extracellular calcium influx in prefrontal cortex neurons involves L-type calcium channels. J Physiol Biochem 65: 125–136, 2009.
49.Xu W, Lipscombe Neuronal Ca(V)1 D.3alpha(1). L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J Neurosci 21: 5944–5951, 2001.
50.Yarbrough GG, Kamath J, Winokur A, Prange AJ Jr. Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions. Med Hypotheses 69: 1249–1256, 2007.
51.Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev 67: 821–870, 2015.
52.Zhang L, Kolaj M, Renaud LP. GIRK-like and TRPC-like conductances mediate thyrotropin-releasing hormone-induced increases in excitability in thalamic paraventricular nucleus neurons. Neuropharmacology 72: 106–115, 2013.
53.Zhang L, Kolaj M, Renaud LP. Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons. Neuroscience 311: 81–91, 2015.
54.Zhang L, Liu Y, Chen X. Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat. J Physiol 568: 469–481, 2005.
55.Zhang L, Renaud LP, Kolaj M. Properties of a T-type Ca²⁺channel-activated slow afterhyperpolarization in thalamic paraventricular nucleus and other thalamic midline neurons. J Neurophysiol 101: 2741–2750, 2009.
56.Zhang Z, Séguéla P. Metabotropic induction of persistent activity in layers II/III of anterior cingulate cortex. Cereb Cortex 20: 2948–2957, 2010.
57.Zhao L, Brinton RD. Estrogen receptor alpha and beta differentially regulate intracellular Ca²⁺ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res 1172: 48–59, 2007.
58.Zheng N, Raman IM. Prolonged postinhibitory rebound firing in the cerebellar nuclei mediated by group I metabotropic glutamate receptor potentiation of L-type calcium currents. J Neurosci 31: 10,283–10,292, 2011.
59.Zuccotti A, Clementi S, Reinbothe T, Torrente A, Vandael DH, Pirone A. Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting. Trends Pharmacol Sci 32: 366–375, 2011.

L-type calcium channels and MAP kinase contribute to thyrotropin-releasing hormone-induced depolarization in thalamic paraventricular nucleus neurons.

Related local records

Studies

Conditions

Cannabinoids and active compounds

Connected local records

Related research

L-type calcium channels and MAP kinase contribute to thyrotropin-releasing hormone-induced depolarization in thalamic paraventricular nucleus neurons

License

Authors

Abstract

Untitled section

Article notes

Untitled section

Author notes

MATERIALS AND METHODS

RESULTS

TRH-induced inward current depends on Ca²⁺ entry through L-type Ca²⁺ channels.

TRH-induced opening of TRPC-like channels relies on functional coupling between ryanodine receptors and L-type Ca²⁺ channels.

MAPK participates in TRH-induced suppression of GIRK-like channels.

DISCUSSION

Perspectives and Significance

GRANTS

DISCLOSURES

AUTHOR CONTRIBUTIONS

ACKNOWLEDGMENTS

REFERENCES

Untitled section

References

Additional materials

Studies

Conditions

Cannabinoids and active compounds

Related research

Abstract

Untitled section

Article notes

Untitled section

Author notes

MATERIALS AND METHODS

RESULTS

TRH-induced inward current depends on Ca2+ entry through L-type Ca2+ channels.

TRH-induced opening of TRPC-like channels relies on functional coupling between ryanodine receptors and L-type Ca2+ channels.

MAPK participates in TRH-induced suppression of GIRK-like channels.

DISCUSSION

Perspectives and Significance

GRANTS

DISCLOSURES

AUTHOR CONTRIBUTIONS

ACKNOWLEDGMENTS

REFERENCES

Untitled section

References

Additional materials

TRH-induced inward current depends on Ca²⁺ entry through L-type Ca²⁺ channels.

TRH-induced opening of TRPC-like channels relies on functional coupling between ryanodine receptors and L-type Ca²⁺ channels.